Short Interest in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Decreases By 42.9%

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) saw a significant decrease in short interest during the month of September. As of September 15th, there was short interest totaling 8,000 shares, a decrease of 42.9% from the August 31st total of 14,000 shares. Based on an average daily trading volume, of 98,500 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily trading volume, of 98,500 shares, the days-to-cover ratio is presently 0.1 days.

Reviva Pharmaceuticals Stock Down 0.6%

NASDAQ RVPHW opened at $0.05 on Friday. The firm’s 50-day moving average is $0.05 and its two-hundred day moving average is $0.05. Reviva Pharmaceuticals has a 12 month low of $0.02 and a 12 month high of $0.78.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.